@article{e00370ba4e9246c98257530e3cdfcd36,
title = "Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study",
keywords = "Allergic, Asthma, China, Eosinophils, Immunoglobulin E, Omalizumab",
author = "{China Omalizumab Study Group} and Jing Li and Changzheng Wang and Chuntao Liu and Jian Kang and Lingfei Kong and Yijiang Huang and Shuang Liu and Mao Huang and Lu Wang and Robert Fogel and Xavier Jaumont and Jing Yang and Nanshan Zhong",
note = "Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = dec,
doi = "10.1016/j.waojou.2020.100469",
language = "English",
volume = "13",
journal = "World Allergy Organization Journal",
issn = "1939-4551",
number = "12",
}